116
Views
14
CrossRef citations to date
0
Altmetric
Drug Evaluation

Iloprost inhalation solution for the treatment of pulmonary arterial hypertension

&
Pages 1921-1930 | Published online: 07 Sep 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

T Karaçor, Z Dogan, E Elibol, M Bulbul & MC Nacar. (2020) Effects of iloprost on experimental ischemia and reperfusion injury in rat ovary. Biotechnic & Histochemistry 95:5, pages 373-380.
Read now
Mark Elphick, Dirk von Hollen, John N Pritchard, Kurt Nikander, Lucy EA Hardaker & Ross HM Hatley. (2015) Factors to consider when selecting a nebulizer for a new inhaled drug product development program. Expert Opinion on Drug Delivery 12:8, pages 1375-1387.
Read now
Ralf Ewert, Sven Gläser, Tom Bollmann & Christoph Schäper. (2011) Inhaled iloprost for therapy in pulmonary arterial hypertension. Expert Review of Respiratory Medicine 5:2, pages 145-152.
Read now
Ralf Ewert, Christoph Schäper, Michael Halank, Sven Gläser & Christian F Opitz. (2009) Inhalative iloprost – pharmacology and clinical application. Expert Opinion on Pharmacotherapy 10:13, pages 2195-2207.
Read now
Ralf Ewert, Sven Gläser & Christian Opitz. (2008) Iloprost in pulmonary hypertension. Expert Review of Respiratory Medicine 2:6, pages 689-702.
Read now

Articles from other publishers (9)

Han Wang, Xin Wang, Teng Li, Daoyuan Lai & Yan Dora Zhang. (2022) Adverse effect signature extraction and prediction for drugs treating COVID-19. Frontiers in Genetics 13.
Crossref
Astrid Bacle, Guillaume Bouzillé, Arnaud Bruyère, Marc Cuggia, Olivier Fardel & Pascal Le Corre. (2021) Drivers of absolute systemic bioavailability after oral pulmonary inhalation in humans. European Journal of Pharmaceutics and Biopharmaceutics 164, pages 36-53.
Crossref
R. Uña Orejón, E. Altit Millán, M. Aguar Fernández & M.P. Ureta Tolsada. (2016) Paraganglioma productor de catecolaminas en una paciente con síndrome de Eisenmenger y ventrículo único. Interés de la administración de óxido nítrico y monitorización hemodinámica mínimamente invasiva. Revista Española de Anestesiología y Reanimación 63:3, pages 172-176.
Crossref
Sunita Sastry & Ronald G. Pearl. 2011. Anesthetic Pharmacology. Anesthetic Pharmacology 767 782 .
Dursun Alehan, Işıl Yıldırım, Murat Şahin, Süheyla Özkutlu, Sema Özer & Tevfik Karagöz. (2011) Long-term inhaled iloprost use in children with pulmonary arterial hypertension. Cardiology in the Young 22:4, pages 396-403.
Crossref
Tobias Gessler, Werner Seeger & Thomas Schmehl. (2011) The potential for inhaled treprostinil in the treatment of pulmonary arterial hypertension. Therapeutic Advances in Respiratory Disease 5:3, pages 195-206.
Crossref
Marcus Jäger, Christoph Zilkens, Bernd Bittersohl, Travis Matheney, Gordana Kozina, Dirk Blondin & Rüdiger Krauspe. (2010) Efficiency of iloprost treatment for osseous malperfusion. International Orthopaedics 35:5, pages 761-765.
Crossref
Tobias GesslerWerner SeegerThomas Schmehl. (2008) Inhaled Prostanoids in the Therapy of Pulmonary Hypertension. Journal of Aerosol Medicine and Pulmonary Drug Delivery 21:1, pages 1-12.
Crossref
Tobias Gessler, Werner Seeger & Thomas Schmehl. (2008) Inhaled Prostanoids in the Therapy of Pulmonary Hypertension. Journal of Aerosol Medicine 0:0, pages 080116123756336-12.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.